Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H19Br |
| Molecular Weight | 363.29 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC1=CC=C(C=C1)C(=C(\Br)C2=CC=CC=C2)\C3=CC=CC=C3
InChI
InChIKey=OQCYTSHIQNPJIC-QURGRASLSA-N
InChI=1S/C22H19Br/c1-2-17-13-15-19(16-14-17)21(18-9-5-3-6-10-18)22(23)20-11-7-4-8-12-20/h3-16H,2H2,1H3/b22-21+
| Molecular Formula | C22H19Br |
| Molecular Weight | 363.29 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Broparestrol, (Z)- is an isomer of Broparestrol -- synthetic, nonsteroidal selective estrogen receptor modulator (SERM) of the triphenylethylene group that has been used in Europe as a dermatological agent and for the treatment of breast cancer. Broparestrol, (Z)- and Broparestrol, (E)- demonstrates antiestrogenic activity but, unlike broparestrol, were never marketed.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 02:09:38 GMT 2023
by
admin
on
Sat Dec 16 02:09:38 GMT 2023
|
| Record UNII |
4F4UXV47YI
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
22393-62-0
Created by
admin on Sat Dec 16 02:09:38 GMT 2023 , Edited by admin on Sat Dec 16 02:09:38 GMT 2023
|
PRIMARY | |||
|
3032769
Created by
admin on Sat Dec 16 02:09:38 GMT 2023 , Edited by admin on Sat Dec 16 02:09:38 GMT 2023
|
PRIMARY | |||
|
m1040
Created by
admin on Sat Dec 16 02:09:38 GMT 2023 , Edited by admin on Sat Dec 16 02:09:38 GMT 2023
|
PRIMARY | Merck Index | ||
|
4F4UXV47YI
Created by
admin on Sat Dec 16 02:09:38 GMT 2023 , Edited by admin on Sat Dec 16 02:09:38 GMT 2023
|
PRIMARY |